Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: A plea for implementation of early switch and early discharge criteria

International Journal of Antimicrobial Agents

Volumn 44, Issue 1, 2014, Pages 56-64

  Eckmann, Christian ^a   Lawson, Wendy ^b   Nathwani, Dilip ^c   Solem, Caitlyn T ^d   Stephens, Jennifer M ^d   Macahilig, Cynthia ^e   Simoneau, Damien ^f   Hajek, Petr ^f   Charbonneau, Claudie ^f   Chambers, Richard ^f   Li, Jim Z ^f   Haider, Seema ^f  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d PHARMERIT INTERNATIONAL   (United States)

^e Medical Data Analytics   (United States)

^f PFIZER INC   (United States)

Author keywords

Economics; Intravenous line days; Intravenous to oral antibiotic switch; Length of stay; Linezolid; Vancomycin

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN; DAPTOMYCIN; DOXYCYCLINE; ERTAPENEM; FOSFOMYCIN; FUSIDIC ACID; IMIPENEM; LEVOFLOXACIN; LINCOMYCIN; LINEZOLID; MEROPENEM; MINOCYCLINE; MOXIFLOXACIN; NETILMICIN; NORFLOXACIN; OFLOXACIN; QUINUPRISTIN; RIFAMPICIN; TEICOPLANIN; TIGECYCLINE; TRIMETHOPRIM; VANCOMYCIN; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; OXAZOLIDINONE DERIVATIVE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; AUSTRIA; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CZECH REPUBLIC; EARLY INTERVENTION; ETHNIC DIFFERENCE; FEMALE; FRANCE; GERMANY; GREECE; HEALTH CARE COST; HEALTH CARE QUALITY; HOSPITAL DISCHARGE; HUMAN; HUMAN TISSUE; IRELAND; ITALY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OBSERVATIONAL STUDY; POLAND; PORTUGAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SLOVAKIA; SOFT TISSUE INFECTION; SPAIN; STAPHYLOCOCCAL SKIN INFECTION; TREATMENT DURATION; UNITED KINGDOM; DRUG ADMINISTRATION; DRUG EFFECTS; ECONOMICS; EUROPE; GROWTH, DEVELOPMENT AND AGING; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; MICROBIOLOGY; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PATHOLOGY; PRACTICE GUIDELINE; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STATISTICS AND NUMERICAL DATA;

ACETAMIDES; ADMINISTRATION, ORAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; EUROPE; FEMALE; HOSPITALIZATION; HUMANS; INJECTIONS, INTRAVENOUS; LENGTH OF STAY; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; OXAZOLIDINONES; PATIENT DISCHARGE; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; VANCOMYCIN;

EID: 84902544271     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2014.04.007     Document Type: Article

References (28)

1. P. Mladovsky, D. Srivastava, J. Cylus, M. Karanikolos, T. Evetovits, and S. Thomson et al. Health policy responses to the financial crisis in Europe 2012 World Heath Organization
2. European Hospital and Healthcare Federation Hospitals in Europe healthcare data 2011 HOPE Publications Brussels, Belgium http://www.hope.be/ 03activities/quality-eu-hospitals/eu-country-profiles/00-hospitals-in-europe- synthesis-vs2011-06.pdf [accessed 01.07.13]
3. A.L. Chapman, S. Dixon, D. Andrews, P.J. Lillie, R. Bazaz, and J.D. Patchett Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective J Antimicrob Chemother 64 2009 1316 1324
4. P.C. Matthews, C.P. Conlon, A.R. Berendt, J. Kayley, L. Jefferies, and B.L. Atkins et al. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years J Antimicrob Chemother 60 2007 356 362
5. A.D. Tice, S.J. Rehm, J.R. Dalovisio, J.S. Bradley, L.P. Martinelli, and D.R. Graham et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines Clin Infect Dis 38 2004 1651 1672
6. B.A. Cunha Oral antibiotic therapy of serious systemic infections Med Clin North Am 90 2006 1197 1222
7. M. Desai, B.D. Franklin, A.H. Holmes, S. Trust, M. Richards, and A. Jacklin et al. A new approach to treatment of resistant Gram-positive infections: potential impact of targeted i.v. to oral switch on length of stay BMC Infect Dis 6 2006 94
8. D. Nathwani, S. Moitra, J. Dunbar, G. Crosby, G. Peterkin, and P. Davey Skin and soft tissue infections: development of a collaborative management plan between community and hospital care Int J Clin Pract 52 1998 456 460
9. S. Parodi, D.C. Rhew, and M.B. Goetz Early switch and early discharge opportunities in intravenous vancomycin treatment of suspected methicillin-resistant staphylococcal species infections J Manag Care Pharm 9 2003 317 326
10. R.A. Seaton, E. Bell, Y. Gourlay, and L. Semple Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone J Antimicrob Chemother 55 2005 764 767
11. D.A. Goff, K.A. Bauer, E.E. Reed, K.B. Stevenson, J.J. Taylor, and J.E. West Is the 'low-hanging fruit' worth picking for antimicrobial stewardship programs? Clin Infect Dis 55 2012 587 592
12. H.S. Sader, D.J. Farrell, and R.N. Jones Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres Int J Antimicrob Agents 36 2010 28 32
13. K. Itani, S. Sorensen, M. Stokes, A. Shelbaya, and P.S. McKinnon A regional comparison of resource utilization in patients with methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infections (cSSTI) treated with linezolid vs vancomycin 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) San Francisco, CA, September 12-15, 2009 2009 American Society for Microbiology Washington, DC [abstract O-1791]
14. World Health Organization. WHO-CHOICE unit cost estimates for service delivery. Updated June 2011. http://www.who.int/choice/country/country-specific/ en/index.html [accessed 31.10.13].
15. T. Adam, D.B. Evans, and C.J. Murray Econometric estimation of country-specific hospital costs Cost Eff Resour Alloc 1 2003 3
16. Eurostat. HICP - inflation rate. http://epp.eurostat.ec.europa.eu/tgm/ table.do?tab=table&language=en&pcode=tec00118&tableSelection= 1&footnotes=yes&labeling=labels&plugin=1 [accessed 01.07.13].
17. S. Coenen, A. Muller, N. Adriaenssens, V. Vankerckhoven, E. Hendrickx, and H. Goossens European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe J Antimicrob Chemother 64 2009 200 205
18. J. Cooke, M. Kubin, T. Morris, J. Ribas, I. Kramer, and W. Kammerer et al. Intravenous and oral antibiotics in respiratory tract infection: an international observational study of hospital practice Pharm World Sci 24 2002 247 255
19. J.G. Bartlett Impact of new oral antibiotics on the treatment of infectious diseases Infect Dis Clin Pract 2 1993 405 413
20. R.R. MacGregor, and A.L. Graziani Oral administration of antibiotics: a rational alternative to the parenteral route Clin Infect Dis 24 1997 457 467
21. K.M. Itani, M.S. Dryden, H. Bhattacharyya, M.J. Kunkel, A.M. Baruch, and J.A. Weigelt Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus Am J Surg 199 2010 804 816
22. M.S. Dryden Complicated skin and soft tissue infection J Antimicrob Chemother 65 Suppl. 3 2010 iii35 iii44
23. D. Nathwani New antibiotics for the management of complicated skin and soft tissue infections: are they any better? Int J Antimicrob Agents 34 Suppl. 1 2009 S24 S29
24. C. Eckmann, and M. Dryden Treatment of complicated skin and soft-tissue infections caused by resistant bacteria: value of linezolid, tigecycline, daptomycin and vancomycin Eur J Med Res 15 2010 554 563
25. R.D. Arbeit, D. Maki, F.P. Tally, E. Campanaro, B.I. Eisenstein, Daptomycin 98-01 and 99-01 Investigators The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections Clin Infect Dis 38 2004 1673 1681
26. P. Prokocimer, C. De Anda, E. Fang, P. Mehra, and A. Das Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial JAMA 309 2013 559 569
27. M. Barrett, E. Wilson, and D. Whalen 2007 HCUP Nationwide Inpatient Sample (NIS) Comparison Report. HCUP Method Series 2007 Report # 2010-03 2010 US Agency for Healthcare Research and Quality http://www.hcup-us.ahrq.gov/db/ nation/nis/reports/2007niscomparisonrpt.jsp [accessed 03.03.14]
28. C.D. Mullins, K. Yang, E. Onukwugha, D.F. Eisenberg, D.E. Myers, and D.B. Huang et al. Rehospitalizations and direct medical costs for cSSSI: linezolid versus vancomycin Am J Pharm Benefits 5 2013 258 267